Please login to the form below

Zalviso

This page shows the latest Zalviso news and features for those working in and with pharma, biotech and healthcare.

Grunenthal and AcelRx’s Zalviso approved in EU

Grunenthal and AcelRx’ s Zalviso approved in EU. Provides new treatment for post-operative pain. ... delivery. AcelRx developed Zalviso and entered into a commercial collaboration with Grunenthal at the end of 2013.

Latest news

Shire and Baxalta drugs among CHMP's latest recommendations

Grunenthal's Zalviso (sufentanil) for the treatment of post-operative pain. A hybrid medicine, Zalviso's application relied in part on the results of studies carried out with a reference product

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

Grünenthal's relentless pursuit of relief

It is our passion to help these patients.”. It is also investing in New Technical Entities (NTEs) which include new formulations and devices, acquiring Zalviso, a combination of a medical device
Pharma deals in September 2015

PDL BioPharma is buying out the majority of the expected royalty stream from EU sales of AcelRX's phase III product, Zalviso for $65m. ... Royalty monetisation. 110. AcelRx Pharmaceuticals. PDL BioPharma. Zalviso sub-lingual formulation of sufentanil.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Chief Medical Writer, Medical Communications: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Account Manager: Competitive salary commensurate with experience

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Business Unit Head, Medical Communications, London: Excellent package

Client Services Director - Med Comms: Great salary and bebefits

Home based, Senior Medical Writer, Medical Communications: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Delivery Manager/ Head of Delivery – Executive Search: Neg

Healthcare PR Director: £100, 000 – £120, 000 benefits

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Home based, Principal Medical Writer, Medical Communications: Excellent package

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Client Services Director – Healthcare Advertising - London: Neg

Editorial Director – Medical Education (MedComms): Neg

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Account Manager: £40, 000 - £45, 000 benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Subscribe to our email news alerts

PMHub

Add my company

PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....